202 related articles for article (PubMed ID: 6695662)
41. [Elevation of 11-dehydro-thromboxane B2 levels in unstable angina].
Koike T; Hattori A; Igarashi Y; Matsubara T; Tamura Y; Yamazoe M; Izumi T; Shibata A
J Cardiol; 1991; 21(4):899-904. PubMed ID: 1844445
[TBL] [Abstract][Full Text] [Related]
42. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease.
Mehta J; Mehta P
Circulation; 1982 Dec; 66(6):1294-9. PubMed ID: 6216027
[TBL] [Abstract][Full Text] [Related]
43. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood.
Marcella JJ; Nichols AB; Johnson LL; Owen J; Reison DS; Kaplan KL; Cannon PJ
J Am Coll Cardiol; 1983 May; 1(5):1185-93. PubMed ID: 6339591
[TBL] [Abstract][Full Text] [Related]
44. [Metabolism of several blood prostaglandins in patients with angina pectoris during helium-neon laser therapy].
Babushkina GV; Shaĭmukhametova LT; Korochkin IM; Kartelishev AV; Kapustina GM; Mingazetdinova LN
Kardiologiia; 1993; 33(2):12-5. PubMed ID: 8084118
[TBL] [Abstract][Full Text] [Related]
45. Blood velocity in the coronary artery circulation: relation to thromboxane A2 levels in coronary sinus in patients with angiographically normal coronary arteries.
Di Donato M; Fantini F; Maioli M; Prisco D; Rogasi PG; Neri Serneri GG
Cathet Cardiovasc Diagn; 1987; 13(3):162-6. PubMed ID: 3594557
[TBL] [Abstract][Full Text] [Related]
46. Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion.
Peterson MB; Huttemeier PC; Zapol WM; Martin EG; Watkins WD
Am J Physiol; 1982 Sep; 243(3):H471-9. PubMed ID: 7051860
[TBL] [Abstract][Full Text] [Related]
47. Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.
Chierchia S; de Caterina R; Crea F; Patrono C; Maseri A
Circulation; 1982 Oct; 66(4):702-5. PubMed ID: 7116586
[TBL] [Abstract][Full Text] [Related]
48. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
Tanabe M; Terashita Z; Nishikawa K; Hirata M
J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
[TBL] [Abstract][Full Text] [Related]
50. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
Ylikorkala O; Puolakka J; Viinikka L
Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
[TBL] [Abstract][Full Text] [Related]
51. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock.
Sakanishi N; Tsunoda Y; Takekawa K; Ikezono E
Bull Tokyo Med Dent Univ; 1983 Jun; 30(2):37-46. PubMed ID: 6580966
[TBL] [Abstract][Full Text] [Related]
52. Thromboxane release during pacing-induced angina.
Verheugt FW; Serruys PW
Circulation; 1981 Jan; 63(1):237. PubMed ID: 7438401
[No Abstract] [Full Text] [Related]
53. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease.
Thomassen AR; Bagger JP; Nielsen TT; Pedersen EB
Int J Cardiol; 1987 Dec; 17(3):267-79. PubMed ID: 2960626
[TBL] [Abstract][Full Text] [Related]
54. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
Willerson JT; Campbell WB; Winniford MD; Schmitz J; Apprill P; Firth BG; Ashton J; Smitherman T; Bush L; Buja LM
Am J Cardiol; 1984 Dec; 54(10):1349-54. PubMed ID: 6391133
[No Abstract] [Full Text] [Related]
55. Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment.
Cortellaro M; Boschetti C; Antoniazzi V; Moreo G; Repetto S; Verna E; Boscarini M; Limido A; Binaghi G; Polli EE
Thromb Haemost; 1983 Dec; 50(4):857-9. PubMed ID: 6665767
[TBL] [Abstract][Full Text] [Related]
56. Platelet activation in unstable coronary disease.
Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations.
Rehr RB; Jackson JA; Winniford MD; Campbell WB; Hillis LD
Am J Cardiol; 1984 Nov; 54(8):971-4. PubMed ID: 6437206
[TBL] [Abstract][Full Text] [Related]
58. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
[TBL] [Abstract][Full Text] [Related]
59. Lack of platelet-activating factor release during reversible myocardial ischaemia.
Montalescot G; Maclouf J; Drobinski G; Mencia-Huerta JM; Ankri A; Grosgogeat Y; Thomas D
Eur Heart J; 1992 Dec; 13(12):1641-4. PubMed ID: 1289094
[TBL] [Abstract][Full Text] [Related]
60. Sequential changes in regional coronary flow during pacing-induced angina pectoris: coronary flow limitation precedes angina.
Wilson JR; Martin JL; Untereker WJ; Laskey W; Hirshfeld JW
Am Heart J; 1984 Feb; 107(2):269-77. PubMed ID: 6695660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
